Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

BACKGROUND: To evaluate the clinical outcome in patients with de novo metastatic nasopharyngeal carcinoma (NPC) treated or not treated with locoregional radiotherapy (LRRT) based on plasma Epstein–Barr virus (EBV) DNA level and tumor response after palliative chemotherapy (PCT). METHODS: From 2007 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xue-Song, Liu, Li-Ting, Liu, Sai-Lan, Guo, Shan-Shan, Wen, Yue-Feng, Xie, Hao-Jun, Tang, Qing-Nan, Liang, Yu-Jing, Li, Xiao-Yun, Yan, Jin-Jie, Ma, Jun, Chen, Qiu-Yan, Tang, Lin-Quan, Mai, Hai-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341516/
https://www.ncbi.nlm.nih.gov/pubmed/30665378
http://dx.doi.org/10.1186/s12885-019-5281-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341516/
https://www.ncbi.nlm.nih.gov/pubmed/30665378
http://dx.doi.org/10.1186/s12885-019-5281-5

Ejemplares similares